Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors

Novel strategies for HIV-1 epitope delivery using foamy viral hybrid proteins and vectors

Bibliographic Details
Main Authors:	Mühle M, Bleiholder A, Hoffmann K, Löchelt M, Denner J
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.
by: Janet Lei, et al.
Published: (2015-01-01)

Feline Foamy Virus-Based Vectors: Advantages of an Authentic Animal Model
by: Martin Löchelt, et al.
Published: (2013-07-01)

Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
by: Arun K. Nalla, et al.
Published: (2016-03-01)

Foamy Virus Vectors for HIV Gene Therapy
by: Grant D. Trobridge, et al.
Published: (2013-10-01)

Delivery of large transgene cassettes by foamy virus vector
by: Nathan Paul Sweeney, et al.
Published: (2017-08-01)

N-Terminally Myristoylated Feline Foamy Virus Gag Allows Env-Independent Budding of Sub-Viral Particles
by: Yong-Boum Kim, et al.
Published: (2011-11-01)

Prototype foamy virus gene expression and hybrid vector development
by: Russell, Rebecca Alice
Published: (2003)

Viral caracterisation of “zoonotic” Foamy viruses
by: Gessain Antoine, et al.
Published: (2011-06-01)

Evaluation and Prediction of the HIV-1 Central Polypurine Tract Influence on Foamy Viral Vectors to Transduce Dividing and Growth-Arrested Cells
by: Sergey Shityakov, et al.
Published: (2014-01-01)

A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
by: Elizabeth M Everson, et al.
Published: (2016-01-01)

Structural and Functional Insights into Foamy Viral Integrase
by: Cha-Gyun Shin, et al.
Published: (2013-07-01)

Regulation of foamy virus protease activity by viral RNA
by: Hartl Maximilian J, et al.
Published: (2011-06-01)

Production and application of foamy virus-derived vectors
by: Patton, Gillian Sarah
Published: (2006)

Twelfth International Foamy Virus Conference—Meeting Report
by: Ottmar Herchenröder, et al.
Published: (2019-02-01)

Infection with Foamy Virus in Wild Ruminants—Evidence for a New Virus Reservoir?
by: Magdalena Materniak-Kornas, et al.
Published: (2020-01-01)

An endogenous foamy-like viral element in the coelacanth genome.
by: Guan-Zhu Han, et al.
Published: (2012-01-01)

Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice
by: John R. Counsell, et al.
Published: (2018-09-01)

Foamy Virus Biology and Its Application for Vector Development
by: Axel Rethwilm, et al.
Published: (2011-05-01)

Foamy virus vector integration and application in gene therapy
by: Sweeney, Nathan Paul
Published: (2015)

Bovine Foamy Virus: Shared and Unique Molecular Features In Vitro and In Vivo
by: Magdalena Materniak-Kornas, et al.
Published: (2019-11-01)

Tenth International Foamy Virus Conference 2014–Achievements and Perspectives
by: Magdalena Materniak, et al.
Published: (2015-03-01)

Large Animal Models for Foamy Virus Vector Gene Therapy
by: Peter A. Horn, et al.
Published: (2012-12-01)

The development of prototypic foamy virus as a gene therapy vector
by: Menon, Dev Christophe
Published: (2009)

Palmitoylation of the Bovine Foamy Virus Envelope Glycoprotein Is Required for Viral Replication
by: Keli Chai, et al.
Published: (2021-12-01)

Viral latency in blood and saliva of simian foamy virus-infected humans.
by: Rejane Rua, et al.
Published: (2013-01-01)

Prototype foamy virus downregulates RelB expression to facilitate viral replication
by: Junshi Zhang, et al.
Published: (2020-10-01)

Isolation of an Equine Foamy Virus and Sero-Epidemiology of the Viral Infection in Horses in Japan
by: Rikio Kirisawa, et al.
Published: (2019-07-01)

TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components
by: Fabian Lindel, et al.
Published: (2019-12-01)

Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein.
by: Caroline Lambert, et al.
Published: (2018-10-01)

In Vitro Evolution of Bovine Foamy Virus Variants with Enhanced Cell-Free Virus Titers and Transmission
by: Qiuying Bao, et al.
Published: (2015-11-01)

Foamy virus zoonotic infections
by: Delia M. Pinto-Santini, et al.
Published: (2017-12-01)

Orthoretroviral-like prototype foamy virus gag-pol expression is compatible with viral replication
by: Reh Juliane, et al.
Published: (2011-08-01)

Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency
by: Md Nasimuzzaman, et al.
Published: (2016-01-01)

Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
by: Jakub Kopycinski, et al.
Published: (2014-01-01)

The First Co-Opted Endogenous Foamy Viruses and the Evolutionary History of Reptilian Foamy Viruses
by: Pakorn Aiewsakun, et al.
Published: (2019-07-01)

Viral vector delivery of Env trimer immunogens
by: Parks CL, et al.
Published: (2012-09-01)

Simian Foamy Virus Co-Infections
by: Shannon M. Murray, et al.
Published: (2019-09-01)

Investigating the intercellular spreading properties of the foamy virus Gag protein.
by: Joelle Tobaly-Tapiero, et al.
Published: (2012-01-01)

The Foamy Virus Gag Proteins: What Makes Them Different?
by: Erik Müllers
Published: (2013-03-01)

Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
by: Reichart T, et al.
Published: (2012-09-01)